Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Vasudeva, Bhat"'
Autor:
Aniketh Umesh, Chandana S. Pai, Vinay Munikoty Venkatesh, Archana Melavarige Venkatagiri, Vasudeva Bhat K, Vishwapriya M. Godkhindi, Kanthilatha Pai
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 9, Iss 3, Pp 164-168 (2024)
Background: Cutaneous invasive fungal infections are a highly feared complication of cancer chemotherapy in children. The increased risk for these infections is often attributed to the profound immunosuppression and neutropenia resulting from intensi
Externí odkaz:
https://doaj.org/article/2e3bed36d86f4caa862401ec3f34ef9a
Publikováno v:
International Journal of Mycobacteriology, Vol 13, Iss 2, Pp 213-217 (2024)
Bacille Calmette–Guérin (BCG) is a live-attenuated vaccine routinely administered to newborns to prevent severe forms of tuberculosis (TB) in TB-endemic countries. Disseminated BCG vaccine disease is a classic feature of children with human immuno
Externí odkaz:
https://doaj.org/article/9870d4eaa0e84dadb1b2a178bf208121
Autor:
Sierra Pellizzari, Vasudeva Bhat, Harjot Athwal, David W. Cescon, Alison L. Allan, Armen Parsyan
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Radioresistance is one of the barriers to developing more effective therapies against the most aggressive, triple-negative, breast cancer (TNBC) subtype. In our previous studies, we showed that inhibition of Polo-like Kinase 4 (PLK4) by a no
Externí odkaz:
https://doaj.org/article/61c0db00737c4c9c86f1edbde2ca4845
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Breast cancer is the most prevalent malignancy among women worldwide. Despite significant advances in treatment, it remains one of the leading causes of female mortality. The inability to effectively treat advanced and/or treatment-resistant breast c
Externí odkaz:
https://doaj.org/article/4eed488c563043a4a2fc4aacd7a9ee8a
Autor:
K., Vasudeva Bhat1 (AUTHOR), Venkatagiri, Archana Melavarige1 (AUTHOR), Venkatesh, Vinay Munikoty1 (AUTHOR), S., Ashwini1 (AUTHOR), Nair, Girish2 (AUTHOR), Dave, Ankeet2 (AUTHOR), Rao, Krithika Shantanu3 (AUTHOR), Salins, Naveen3 (AUTHOR), Rao, Sharath Kumar4 (AUTHOR)
Publikováno v:
Indian Journal of Medical & Paediatric Oncology. Apr2024, Vol. 45 Issue 2, p173-175. 3p.
Autor:
Archana MV, Kalasekhar VS, Vinay Munikoty, Ramitha R. Bhat, Atul Achyutrao, Vani Lakshmi R, Vasudeva Bhat K
Publikováno v:
South Asian Journal of Cancer (2023)
Abstract Vasudeva Bhat K Introduction L-asparaginase is an essential chemotherapeutic agent in the therapy of acute lymphoblastic leukemia (ALL), which has led to improvement in survival. In low- and middle-income countries like India, the outcomes
Externí odkaz:
https://doaj.org/article/18e25869d2b3461d9b1f40826b99e2f9
Autor:
Cory Lefebvre, Sierra Pellizzari, Vasudeva Bhat, Kristina Jurcic, David W. Litchfield, Alison L. Allan
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2406 (2023)
Resistance to protein tyrosine kinase inhibitors (TKIs) presents a significant challenge in therapeutic target development for cancers such as triple-negative breast cancer (TNBC), where conventional therapies are ineffective at combatting systemic d
Externí odkaz:
https://doaj.org/article/ab995c5c0bbf4b7fb7dd90ecbe7e702e
Autor:
Armen Parsyan, Jennifer Cruickshank, Kelsey Hodgson, Drew Wakeham, Sierra Pellizzari, Vasudeva Bhat, David W. Cescon
Publikováno v:
Breast, Vol 58, Iss , Pp 6-9 (2021)
Development of novel multimodality radiotherapy treatments in metastatic breast cancer, especially in the most aggressive triple negative (TNBC) subtype, is of significant clinical interest. Here we show that a novel inhibitor of Polo-Like Kinase 4 (
Externí odkaz:
https://doaj.org/article/d129a108948546669208676583fd01f1
Autor:
Robert Olson, Lindsay Mathews, Mitchell Liu, Devin Schellenberg, Benjamin Mou, Tanya Berrang, Stephen Harrow, Rohann J. M. Correa, Vasudeva Bhat, Howard Pai, Islam Mohamed, Stacy Miller, Famke Schneiders, Joanna Laba, Derek Wilke, Sashendra Senthi, Alexander V. Louie, Anand Swaminath, Anthony Chalmers, Stewart Gaede, Andrew Warner, Tanja D. de Gruijl, Alison Allan, David A. Palma
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background A recent randomized phase II trial evaluated stereotactic ablative radiotherapy (SABR) in a group of patients with a small burden of oligometastatic disease (mostly with 1–3 metastatic lesions), and found that SABR was associate
Externí odkaz:
https://doaj.org/article/2164cc83a76d4a73a0be273fbb56cec5
Autor:
Chandana S. Pai, K. Vasudeva Bhat, M.V. Archana, M.V. Vinay, Ramitha R. Bhat, Atul Achyutrao, Arjun Ashok, Krishnananda Prabhu
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 4, Pp S54- (2022)
Externí odkaz:
https://doaj.org/article/2c3d101e52ae4a60a9db1a1f212cc213